0
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Melatonin as a radioprotective agent against flattening filter and flattening filter-free beam in radiotherapy-induced lung tissue damage

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Received 10 Jul 2023, Accepted 11 Jul 2024, Published online: 29 Jul 2024

References

  • Aghazadeh S, Azarnia M, Shirazi A, Mahdavi SR, Zangii BM. 2007. Melatonin as a protective agent in spinal cord damage after gamma irradiation. Rep Pract Oncol Radiother. 12(2):95–99. doi:10.1016/S1507-1367(10)60045-4
  • Amini P, Mirtavoos-Mahyari H, Motevaseli E, Shabeeb D, Musa AE, Cheki M, Farhood B, Yahyapour R, Shirazi A, Goushbolagh NA, et al. 2019. Mechanisms for radioprotection by melatonin; can it be used as a radiation countermeasure? Curr Mol Pharmacol. 12(1):2–11. doi:10.2174/1874467211666180802164449
  • Aras S, Efendioğlu M, Wulamujiang A, Ozkanli SS, Keleş MS, Tanzer İO. 2021. Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat. Int J Radiat Biol. 97(3):348–355. doi:10.1080/09553002.2021.1864047
  • Aras S, Tanzer İO, Can Ü, Sümer E, Baydili KN. 2021. The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy. Radiat Phys Chem. 179:109206. doi:10.1016/j.radphyschem.2020.109206
  • Aras S, Tanzer IO, Karacavus S, Sayir N, Erdem E, Hacimustafaoglu F, Erdogan CE, Sapmaz T, Ikizceli T, Pence HH, et al. 2021. Radioprotective effect of melatonin against flattening filter-free irradiation-induced rat parotid gland damage. Radiat Eff Defects Solids. 176(7–8):621–637. doi:10.1080/10420150.2021.1898392
  • Aras S, Tanzer İO, Sayir N, Keleş MS, Özgeriş FB. 2021. Radiobiological comparison of flattening filter (FF) and flattening filter-free (FFF) beam in rat laryngeal tissue. Int J Radiat Biol. 97(2):249–255. doi:10.1080/09553002.2021.1857457
  • Arendt J, Skene DJ. 2005. Melatonin as a chronobiotic. Sleep Med Rev. 9(1):25–39. doi:10.1016/j.smrv.2004.05.002
  • Azmoonfar R, Amini P, Yahyapour R, Rezaeyan A, Tavassoli A, Motevaseli E, Khodamoradi E, Shabeeb D, Musa AE, Najafi M. 2020. Mitigation of radiation-induced pneumonitis and lung fibrosis using alpha-lipoic acid and resveratrol. Antiinflamm Antiallergy Agents Med Chem. 19(2):149–157. doi:10.2174/1871523018666190319144020
  • Begg AC, Stewart FA, Vens C. 2011. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 11(4):239–253. doi:10.1038/NRC3007
  • Cakmak Karaer I, Simsek G, Yildiz A, Vardi N, Polat A, Tanbek K, Gurocak S, Parlakpinar H. 2016. Melatonin’s protective effect on the salivary gland against ionized radiation damage in rats. J Oral Pathol Med. 45(6):444–449. doi:10.1111/jop.12386
  • Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. 2013. Melatonin: buffering the immune system. Int J Mol Sci. 14(4):8638–8683. doi:10.3390/IJMS14048638
  • Chen CQ, Fichna J, Bashashati M, Li YY, Storr M. 2011. Distribution, function and physiological role of melatonin in the lower gut. World J Gastroenterol. 17(34):3888–3898. doi:10.3748/WJG.V17.I34.3888
  • Fardid R, Salajegheh A, Mosleh-Shirazi MA, Sharifzadeh S, Okhovat MA, Najafi M, Rezaeyan A, Abaszadeh A. 2017. Melatonin ameliorates the production of COX-2, iNOS, and the formation of 8-OHdG in non-targeted lung tissue after pelvic irradiation. Cell J. 19(2):324–331. doi:10.22074/CELLJ.2016.3857
  • Farhood B, Aliasgharzadeh A, Amini P, Rezaeyan A, Tavassoli A, Motevaseli E, Shabeeb D, Musa AE, Najafi M. 2019. Mitigation of radiation-induced lung pneumonitis and fibrosis using metformin and melatonin: a histopathological study. Medicina. 55(8):417. doi:10.3390/medicina55080417
  • Farhood B, Goradel NH, Mortezaee K, Khanlarkhani N, Salehi E, Nashtaei MS, Mirtavoos-Mahyari H, Motevaseli E, Shabeeb D, Musa AE, et al. 2019. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization. Clin Transl Oncol. 21(3):268–279. doi:10.1007/S12094-018-1934-0
  • Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R. 2017. Melatonin as an anti-inflammatory agent modulating inflammasome activation. Int J Endocrinol. 2017:1835195. doi:10.1155/2017/1835195
  • Ghobadi A, Shirazi A, Najafi M, Kahkesh M, Rezapoor S. 2017. Melatonin ameliorates radiation-induced oxidative stress at targeted and nontargeted lung tissue. J Med Phys. 42(4):241–244. doi:10.4103/JMP.JMP_60_17
  • Gozal F, Gondhowiardjo SA, Kodrat H, Wibowo WE. 2021. Dosimetric analysis of three-dimensional conformal radiotherapy, intensity-modulated radiotherapy—step and shoot, helical tomotherapy, and volumetric modulated arc therapy in prostate cancer radiotherapy. J Cancer Res Ther. 17(4):893–900. doi:10.4103/JCRT.JCRT_57_19
  • Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature. 461(7267):1071–1078. doi:10.1038/NATURE08467
  • Karan T, Moiseenko V, Gill B, Horwood R, Kyle A, Minchinton AI. 2013. Radiobiological effects of altering dose rate in filter-free photon beams. Phys Med Biol. 58(4):1075–1082. doi:10.1088/0031-9155/58/4/1075
  • Khan S, Adhikari JS, Rizvi MA, Chaudhury NK. 2016. Melatonin attenuates 60 Co gamma-ray-induced hematopoietic, immunological and gastrointestinal injuries in C57BL/6 male mice. Environ Toxicol. 32(2):501–518. doi:10.1002/tox.22254
  • Lasio G, Guerrero M, Goetz W, Lima F, Baulch JE. 2014. Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival. Radiat Environ Biophys. 53(4):671–676. doi:10.1007/S00411-014-0565-2
  • Liauw SL, Connell PP, Weichselbaum RR. 2013. New paradigms and future challenges in radiation oncology: an update of biological targets and technology. Sci Transl Med. 5(173):173sr2. doi:10.1126/SCITRANSLMED.3005148
  • Ling CC, Gerweck LE, Zaider M, Yorke E. 2010. Dose-rate effects in external beam radiotherapy redux. Radiother Oncol. 95(3):261–268. doi:10.1016/J.RADONC.2010.03.014
  • Lohse I, Lang S, Hrbacek J, Scheidegger S, Bodis S, MacEdo NS, Feng J, Lütolf UM, Zaugg K. 2011. Effect of high dose per pulse flattening filter-free beams on cancer cell survival. Radiother Oncol. 101(1):226–232. doi:10.1016/J.RADONC.2011.05.072
  • Nakano H, Minami K, Yagi M, Imaizumi H, Otani Y, Inoue S, Takashina M, Seo Y, Takahashi Y, Sumida I, et al. 2018. Radiobiological effects of flattening filter-free photon beams on A549 non-small-cell lung cancer cells. J Radiat Res. 59(4):442–445. doi:10.1093/JRR/RRY041
  • Navarria P, Ascolese AM, Mancosu P, Alongi F, Clerici E, Tozzi A, Iftode C, Reggiori G, Tomatis S, Infante M, et al. 2013. Volumetric modulated arc therapy with flattening filter free (FFF) beams for stereotactic body radiation therapy (SBRT) in patients with medically inoperable early stage non small cell lung cancer (NSCLC). Radiother Oncol. 107(3):414–418. doi:10.1016/J.RADONC.2013.04.016
  • Oktaria S, Lerch MLF, Rosenfeld AB, Tehei M, Corde S. 2017. In vitro investigation of the dose–rate effect on the biological effectiveness of megavoltage X-ray radiation doses. Appl Radiat Isot. 128:114–119. doi:10.1016/J.APRADISO.2017.07.008
  • Pikalova LV, Legeza VI, Ivanov MB, Zhakovko EB. 2011. Experimental study of cytoprotective effect of melatonin in radiation exposure. Bull Exp Biol Med. 152(1):76–78. doi:10.1007/S10517-011-1458-X
  • Prendergast BM, Dobelbower MC, Bonner JA, Popple RA, Baden CJ, Minnich DJ, Cerfolio RJ, Spencer SA, Fiveash JB. 2013. Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute. Radiat Oncol. 8(1):273. doi:10.1186/1748-717X-8-273
  • Reiter RJ. 1995. The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol. 30(3–4):199–212. doi:10.1016/0531-5565(94)00045-5
  • Scorsetti M, Alongi F, Castiglioni S, Clivio A, Fogliata A, Lobefalo F, Mancosu P, Navarria P, Palumbo V, Pellegrini C, et al. 2011. Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments. Radiat Oncol. 6(1):113. doi:10.1186/1748-717X-6-113
  • Seely D, Wu P, Fritz H, Kennedy DA, Tsui T, Seely AJ, Mills E. 2012. Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 11(4):293–303. doi:10.1177/1534735411425484
  • Tahamtan R, Monfared AS, Tahamtani Y, Tavassoli A, Akmali M, Mosleh-Shirazi MA, Naghizadeh MM, Ghasemi D, Keshavarz M, Haddadi GH. 2015. Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats. Cell J. 17(1):111–120. doi:10.22074/CELLJ.2015.517
  • Vural H, Sabuncu T, Arslan SO, Aksoy N. 2001. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res. 31(3):193–198. doi:10.1034/J.1600-079X.2001.310301.X
  • Yu GM, Kubota H, Okita M, Maeda T. 2017. The anti-inflammatory and antioxidant effects of melatonin on LPS-stimulated bovine mammary epithelial cells. PLOS One. 12(5):e0178525. doi:10.1371/JOURNAL.PONE.0178525
  • Yu H, Dickson EJ, Jung SR, Koh DS, Hille B. 2016. High membrane permeability for melatonin. J Gen Physiol. 147(1):63–76. doi:10.1085/JGP.201511526
  • Zhang HM, Zhang Y. 2014. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res. 57(2):131–146. doi:10.1111/JPI.12162

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.